Regression of Femoral Atherosclerosis in Humans: Methodological and Clinical Problems Associated with Studies of Femoral Atherosclerosis Development as Assessed by Angiograms

  • Anders G. Olsson
  • Uno Erikson
  • Gunnar Helmius
  • Anders Hemmingsson
  • Gunnar Ruhn


Ischemic heart disease is the most prevalent clinical consequence of atherosclerosis.1 Atherosclerotic peripheral artery disease is, however, one of the most frequent causes of disability in the middle-aged and elderly.2


Nicotinic Acid Serum Lipid Intermittent Claudication Hyperlipidemic Patient Hyperlipidemic Subject 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    T. Gordon, P. Sorlie, and W. B. Kannel, An epidemiological investigation of cardiovascular disease, Section 27, Coronary Heart Disease, Atherothrombotic Brain Infarction, Intermittent Claudication — A Multivariate Analysis of Some Factors Related to Their Incidence, Framingham Study, 16-year Follow-up. US Dept. of Health, Education and Welfare (1971).Google Scholar
  2. 2.
    W. G. Hughson, J. I. Mann, and I. Garrod, Intermittent claudication: prevalence and risk factors, Br. Med. J. i: 179 (1978).Google Scholar
  3. 3.
    E. Wetteren, R. O. Bauer, and R. Busse, Arterial dynamics, in: “Cardiovascular and Pulmonary Dynamics,” INSERM Euromec, 71: 17 (1977).Google Scholar
  4. 4.
    S. L. Wilens, The resorption of arterial atheromatous deposits in wasting disease, Am. J. Pathol. 23: 793 (1947).Google Scholar
  5. 5.
    S. N. Jagannathan, W. E. Connor, W. H. Baker, and A. K. Bhattacharyya, The turnover of cholesterol in human atherosclerotic arteries, J. Clin. Invest. 54: 366 (1974).CrossRefGoogle Scholar
  6. 6.
    C.-R. Ost and S. Stenson, Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid, Scand. J. Clin. Lab. Invest Suppl. 99: 241 (1967).Google Scholar
  7. 7.
    R. Zelis, D. T. Mason, E. Braunwald, and R. I. Levy, Effects of hyperlipoproteinemias and their treatment on the peripheral circulation, J. Clin. Invest. 49: 1007 (1970).CrossRefGoogle Scholar
  8. 8.
    D. W. Crawford, S. H. Brooks, R. Barndt Jr., and D. H. Blankenhorn, Measurement of atherosclerotic luminal irregularity and obstruction by radiographic densitometry, Invest. Radiol. 12: 307 (1977).CrossRefGoogle Scholar
  9. 9.
    D. H. Blankenhorn, S. H. Brooks, R. H. Selzer, and R. Barndt, The rate of atherosclerosis change during treatment of hyperlipoproteinemia, Circulation 57: 355 (1978).CrossRefGoogle Scholar
  10. 10.
    R. Barndt Jr., D. H. Blankenhorn, D. W. Crawford, and S. H. Brooks, Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients, Ann. Intern. Med. 86: 139 (1977).CrossRefGoogle Scholar
  11. 11.
    A. G. Olsson, U. Erikson, G. Helmius, A. Hemmingsson, and G. Ruhn, Measurement of atherosclerosis by arteriography and microdensitometry: model and clinical investigations, Proceedings of the 6th International Symposium on Atherosclerosis, Berlin, 1982, Springer Verlag (in press).Google Scholar
  12. 12.
    R. G. M. Duffield, N. E. Miller, C. W. Jamieson, and B. Lewis, A controlled trial of plasma lipid reduction in peripheral atherosclerosis — an interim report, Br. J. Surg. 69(Suppl.): S3 (1982).CrossRefGoogle Scholar
  13. 13.
    A. G. Olsson and B. Eklund, Studies in asymptomatic primary hyperlipidaemia. V. Peripheral circulation., ActaMedScand. 198: 197 (1975).Google Scholar
  14. 14.
    R. Barndt Jr., D. H. Blankenhorn, and D. W. Crawford, Prevalence of asymptomatic femoral artery atheromas in hyperlipoproteinemic patients, Atherosclerosis 20: 253 (1974).CrossRefGoogle Scholar
  15. 15.
    D. H. Blankenhorn, Progress on a lipid lowering trial in men with coronary bypass surgery, in: “Treatment of Hyperlipidemia,” L. A. Carlson and A. G. Olsson, eds., Raven Press (in press).Google Scholar
  16. 16.
    H. Buchwald, R. B. Moore, and R. L. Varco III, Clinical status of the partial ileal bypass operation (Part three of a three-part presentation), Circulation 49–50, Suppl. 1: 22 (1974).Google Scholar
  17. 17.
    H. Buchwald, R. B. Moore, R. D. Rucker Jr., K. Amplatz, W. R. Castaneda, R. A. Francoz, R. C. Pasternak, R. L. Varco, and the POSCH Arteriography Review Panel, Clinical angiographic regression of atherosclerosis after partial ileal bypass, Atherosclerosis 46: 117 (1983).CrossRefGoogle Scholar
  18. 18.
    L. A. Solberg and J. P. Strong, Risk factors and atherosclerotic lesions, a review of autopsy studied, Arteriosclerosis 3: 187 (1983).CrossRefGoogle Scholar
  19. 19.
    G. Ruhn, U. Erikson, G. Helmius, and A. Hemmingsson, Computerized quantitation of atherosclerosis in an experimental model, ActaRadiol [Diagn]. 23: 621 (1982).Google Scholar
  20. 20.
    A. G. Olsson, E. Erickson, G. Helmius, A. Hemmingsson, and G. Ruhn, On the effect of serum lipid lowering on femoral atherosclerosis in asymptomatic hyperlipoproteinemia, in: “Treatment of Hyperlipidemia,” L. A. Carlson and A. G. Olsson, eds., Raven Press (in press).Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Anders G. Olsson
    • 1
  • Uno Erikson
    • 2
  • Gunnar Helmius
    • 2
  • Anders Hemmingsson
    • 2
  • Gunnar Ruhn
    • 2
  1. 1.King Gustaf V Research InstituteKarolinska InstituteStockholmSweden
  2. 2.Department of Diagnostic RadiologyUniversity HospitalUppsalaSweden

Personalised recommendations